Navigation Links
Measuring hidden parasites in falciparum malaria

A new technique for measuring hidden malaria parasites and assessing severity of disease is described in a paper published on Aug 23rd in PLoS Medicine. Researchers led by Professor Nick White from Mahidol University, Thailand, looked at patients with the most dangerous type of malaria, falciparum malaria. Usually the severity of disease is measured by counting the number of parasites in the blood under the microscope, but this method ignores parasites which are in red blood cells trapped (sequestered) in the capillaries--the smallest blood vessels in the body.

The researchers estimated total amount of malaria parasites in the body by measuring a protein--Histidine-rich protein 2 (PfHRP2)--which is liberated into the blood when malaria-infected red cells spilt. Using this method in 337 patients with varying severity of falciparum malaria they found that the average parasite burden was more than six times higher in patients with severe malaria than in patients hospitalized without signs of severe disease, and was highest in patients who died. This finding fits with current thinking that sequestration of red cells containing the mature forms of the parasite is the most important pathological process in falciparum malaria.

Approximately 40% of the world's population, mostly living in the world's poorest countries, is at risk of malaria. In the tropical and subtropical regions of the world, malaria causes 300 million acute illnesses and at least 1 million deaths annually.

Estimates of plasma PfHRP2 concentrations may be useful as a research tool to assess patients' parasite loads and may also provide one way of assessing the severity of a patient's disease.


'"/>

Source:Public Library of Science


Page: 1

Related biology news :

1. Measuring the impact of post-genomics on Mediterranean populations
2. Measuring hormone cuts antibiotic use in half in pneumonia patients
3. Measuring Enzymes At End Of Cancer Pathway Predicts Outcome Of Tarceva, Taxol
4. Measuring artery repair cells could become new heart disease test
5. Finding hidden invaders in a Hawaiian rain forest
6. UCLA cancer researchers shake loose hidden biomarker
7. Envisat and ERS-2 reveal hidden side of Hurricane Rita
8. Computer modeling reveals hidden conversations within cells
9. Viagras hidden help for wildlife
10. Clues to breast cancer hidden inside stem cells
11. Squid skin reveals hidden messages
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
(Date:4/15/2016)... 2016 Research and Markets has ... Market 2016-2020,"  report to their offering.  , ... ,The global gait biometrics market is expected to ... period 2016-2020. Gait analysis generates multiple ... used to compute factors that are not or ...
(Date:3/29/2016)... 29, 2016 LegacyXChange, Inc. (OTC: ... and SelectaDNA/CSI Protect are pleased to announce our successful ... a variety of writing instruments, ensuring athletes signatures against ... collectibles from athletes on LegacyXChange will be assured of ... DNA. Bill Bollander , CEO states, ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 2016 Houston Methodist Willowbrook Hospital has ... Association to serve as their official health care ... Willowbrook will provide sponsorship support, athletic training services, ... coaches, volunteers, athletes and families. "We ... Association and to bring Houston Methodist quality services ...
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... at the Pennsylvania Convention Center and will showcase its product’s latest features from ... also be presenting a scientific poster on Disrupting Clinical Trials in The Cloud ...
Breaking Biology Technology: